Connect with us

Business

FDA Adviser Quits Over ‘Probably The Worst’ Approval Decision Of Alzheimer’s Drug – HuffPost

The controversial drug, called Aduhelm, costs $56,000 a year and some patients could face copayments of $11,500 annually.

Published

on

Article feature image
ADVERTISEMENT

WASHINGTON (AP) A new $56,000-a-year Alzheimers drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.
The drug,…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
A new milestone for Bitcoin, COVID hits conference, Buterin’s DOGE payday – Cointelegraph
Article feature image
Jay Leno Attempts Quarter-Mile Record In Tesla Model S Plaid – Motor1
Article feature image
Taco Bell offering free tacos for COVID-19 vaccines — but only in this state – Fox News